The Explosive Growth of China's Billion-Dollar Pharmaceutical Market
At present, China's stomach medicine market has shown a very broad potential. According to detailed statistical data, in this vast land, there are more than 120 million patients with stomach diseases, which accounts for 9.23% of the total population of the country, highlighting the universality and severity of stomach problems.
In terms of sales channels, whether it is traditional physical pharmacies or emerging online retail platforms, proprietary Chinese medicine stomach medicine has shown a steady and strong growth trend. Specifically, in the territory of physical pharmacies, in the first half of 2023, the sales of Chinese patent medicine stomach medicine has proudly exceeded the 1.42 billion yuan mark, achieving a steady growth of 1.06% year-on-year. In this prosperous scene, Qingdao Guofeng Pharmaceutical's Kuaiwei tablet and Li Wanshan Pharmaceutical Factory's He Weizheng Pill are emerging, and their sales growth is particularly remarkable, becoming the market leader.
Looking at the online channels, we can also feel that vigorous development vitality. According to data, drug sales in online pharmacies in 2021 have reached 36.8 billion yuan, soaring by 51.5% year-on-year, of which the growth of OTC drugs is like a runaway, unstoppable. In this wave of growth, Yunnan Plant Pharmaceutical's Hawthorn Poria granules and Shaanxi Fangzhou Pharmaceutical's Yangweishu tablets and other stomach medicine brands have stood out with excellent performance, and their sales growth has achieved amazing surpass, both more than 1000%, becoming a shining star in the online market.
China's huge population of stomach disease patients has undoubtedly laid an indestructible cornerstone for the development of the Chinese patent medicine stomach medicine market. Looking forward to the future, with the continuous evolution of residents' lifestyles and the increasing attention of consumers to health issues, the unlimited opportunities contained in the stomach medicine market will be more fully released and displayed. We have reason to believe that in the near future, China's stomach medicine market will usher in a more brilliant chapter of development.
2026-10-21
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
From Coffee Waste to Superfood Additive: EU Declares Pectin-Rich Arabica Extract Safe for Food Use
-
Australia Approves Lab-Grown “Milk Sugar” for Babies—A Breakthrough in Infant Nutrition
-
U.S. 10% Temporary Tariff Expires, New Section 301 Tariffs Not Yet Implemented
-
Profits Are Rising, but So Are the Risks—China’s Coatings Industry Is Living Through Its Most Awkward Year
-
Crude Tanker Freight From the Americas to Asia Tops $80 Million per Voyage Amid Global Shipping Crunch
-
“Clearing the Floor”: DKSH’s Privatization of Its Malaysian Subsidiary Signals a Silent Power Shift in Asia’s Supply Chain
-
Canada Scraps PV Module Tariffs! Market Reopens, Demand for Supporting Chinese Chemical New Materials Set to Take Off
-
When SWIFT Goes On-Chain: A New 24/7 Order for Cross-Border Payments
-
MDI Price Surge Hits EMEAI: Is This a Market Correction or the Beginning of a Supply Crisis?
-
“Deregulation” or “Concession”? The Hidden Crisis Behind India’s Repeal of QCOs on Seven Key Petrochemicals
Recommend Reading
-
The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share
-
Chemours Sells Its Former Titanium Dioxide Site in Taiwan: Turning a “White Powder” Factory into “Wind Power Real Estate” for $360 Million—Buying Not Cash, But Breathing Room
-
Wanhua Chemical’s 2025 Revenue Exceeds RMB 200 Billion While Net Profit Remains Under Pressure
-
Korea’s First Petrochemical Restructuring Approved, LDPE Market Concentration Surges to 82%
-
Hormuz Traffic Remains 90% Below Pre-Conflict Levels as Limited Tanker Access Offers Partial Relief
-
This Week's Activated Carbon Prices Rise (11.17-11.21)
-
Weak Demand Leads to a Decline in n-Butanol Prices in China
-
Recent EVA Market Trend Continues to Be Weak in China
-
Sluggish Demand Sends Hydrogen Peroxide Market Down
-
Supply Reduction Leads to Steady Increase in Cyclohexanone Prices in Shandong, China